首页>
外国专利>
Methods for Culturing Mesenchymal Stem Cell Derived from Placenta Amniotic Membrane and Compositions Comprising Mesenchymal Stem Cell for Repairing Peripheral arterial disease
Methods for Culturing Mesenchymal Stem Cell Derived from Placenta Amniotic Membrane and Compositions Comprising Mesenchymal Stem Cell for Repairing Peripheral arterial disease
展开▼
机译:培养源自胎盘羊膜的间充质干细胞和包含间充质干细胞的组合物修复外周动脉疾病的方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
PURPOSE: A pharmaceutical composition of amniotic mesenchymal stem cells (AMMs) is provided to have excellent angiogenesis effect in an animal model of hindlimb ischemia. CONSTITUTION: A method for differentiating human AMMs into vascular endothelial cells comprises the steps of: culturing the AMMs in a medium containing serum; and culturing the AMMs in a complete medium for differentiating the AMMs to vascular endothelial cells. A pharmaceutical composition for preventing and treating hindlimb ischemia, ischemic myocardial infarction, ischemic peripheral vascular disease, diabetic necrosis, diabetic peripheral vascular disease, or Buerger's disease contains a pharmaceutically effective amount of the AMMs and a pharmaceutically acceptable carrier.
展开▼